<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font20 { font-size : 20; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font20">and </span>
   <span class="font13">for </span>
   <span class="font13">nasal </span>
   <span class="font13">[]. </span>
   <span class="font12">drug </span>
   <span class="font12">that </span>
   <span class="font12">with </span>
   <span class="font12">brain </span>
   <span class="font12">drugs </span>
   <span class="font12">The </span>
   <span class="font11">are </span>
   <span class="font11">able </span>
   <span class="font11">antiviral </span>
   <span class="font11">was </span>
   <span class="font11">can </span>
   <span class="font11">{background </span>
   <span class="font11">efflux </span>
   <span class="font11">their </span>
   <span class="font11">inhibitors </span>
   <span class="font11">AET </span>
   <span class="font11">administration </span>
   <span class="font11">formulations </span>
   <span class="font11">order </span>
   <span class="font11">P-gp </span>
   <span class="font11">central </span>
   <span class="font11">AZT </span>
   <span class="font11">delivery </span>
   <span class="font11">nervous </span>
   <span class="font11">human </span>
   <span class="font11">margin </span>
   <span class="font11">transport </span>
   <span class="font11">HIV </span>
   <span class="font11">were </span>
   <span class="font11">{border-style </span>
   <span class="font10">antiretroviral </span>
   <span class="font10">into </span>
   <span class="font10">olfactory </span>
   <span class="font10">prodrug </span>
   <span class="font10">px;} </span>
   <span class="font10">transporters </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">CNS </span>
   <span class="font10">P-glycoprotein </span>
   <span class="font10">from </span>
   <span class="font10">obtained </span>
   <span class="font10">cells </span>
   <span class="font10">this </span>
   <span class="font10">virus </span>
   <span class="font10">been </span>
   <span class="font10">chitosan </span>
   <span class="font10">activity </span>
   <span class="font10">after </span>
   <span class="font10">appear </span>
   <span class="font10">endothelial </span>
   <span class="font10">not </span>
   <span class="font10">systems </span>
   <span class="font10">these </span>
   <span class="font10">formulation </span>
   <span class="font10">intranasal </span>
   <span class="font10">known </span>
   <span class="font10">substrates </span>
   <span class="font10">system </span>
   <span class="font10">uptake </span>
   <span class="font10">which </span>
   <span class="font10">zidovudine </span>
   <span class="font10">Pharm. </span>
   <span class="font10">[], </span>
   <span class="font10">expression </span>
   <span class="font10">induce </span>
   <span class="font10">macrophages </span>
   <span class="font10">Antiviral </span>
   <span class="font10">[,]. </span>
   <span class="font10">active </span>
   <span class="font10">based </span>
   <span class="font10">cell </span>
   <span class="font10">has </span>
   <span class="font10">its </span>
   <span class="font10">nanoparticles </span>
   <span class="font10">receptor </span>
   <span class="font10">saquinavir </span>
   <span class="font10">target </span>
   <span class="font10">Moreover, </span>
   <span class="font10">This </span>
   <span class="font10">have </span>
   <span class="font10">high </span>
   <span class="font10">new </span>
   <span class="font10">nose-to-brain </span>
   <span class="font10">particular, </span>
   <span class="font10">presence </span>
   <span class="font10">severe </span>
   <span class="font10">targeting </span>
   <span class="font10">they </span>
   <span class="font10">BBB </span>
   <span class="font10">Nasal </span>
   <span class="font10">These </span>
   <span class="font10">cavity </span>
   <span class="font10">distribution </span>
   <span class="font10">effects </span>
   <span class="font10">important </span>
   <span class="font10">increase </span>
   <span class="font10">mucoadhesive </span>
   <span class="font10">prodrugs </span>
   <span class="font10">resistance </span>
   <span class="font10">transporter </span>
   <span class="font10">type </span>
   <span class="font10">vitro </span>
   <span class="font10">HIV- </span>
   <span class="font10">Virus </span>
   <span class="font10">acid </span>
   <span class="font10">against </span>
   <span class="font10">barrier </span>
   <span class="font10">blood-brain </span>
   <span class="font10">concentrations </span>
   <span class="font10">following </span>
   <span class="font10">higher </span>
   <span class="font10">may </span>
   <span class="font10">microparticles </span>
   <span class="font10">microvessel </span>
   <span class="font10">pathway </span>
   <span class="font10">properties </span>
   <span class="font10">px; </span>
   <span class="font10">several </span>
   <span class="font10">than </span>
   <span class="font10">therapeutic </span>
   <span class="font10">using </span>
   <span class="font10">where </span>
   <span class="font10">{font-family </span>
   <span class="font10">CSF </span>
   <span class="font10">[,,]. </span>
   <span class="font10">administered </span>
   <span class="font10">appears </span>
   <span class="font10">but </span>
   <span class="font10">deposition </span>
   <span class="font10">efficacy </span>
   <span class="font10">enhance </span>
   <span class="font10">font-size </span>
   <span class="font10">gene </span>
   <span class="font10">increased </span>
   <span class="font10">induced </span>
   <span class="font10">inhibit </span>
   <span class="font10">innovative </span>
   <span class="font10">intravenous </span>
   <span class="font10">multidrug </span>
   <span class="font10">ritonavir, </span>
   <span class="font10">treatment </span>
   <span class="font10">unwanted </span>
   <span class="font10">Drugs </span>
   <span class="font10">Exp. </span>
   <span class="font10">MRP- </span>
   <span class="font10">Pharmacol. </span>
   <span class="font10">abacavir </span>
   <span class="font10">absorption </span>
   <span class="font10">across </span>
   <span class="font10">administration, </span>
   <span class="font10">approach </span>
   <span class="font10">cassette </span>
   <span class="font10">conjugation </span>
   <span class="font10">currently </span>
   <span class="font10">devices </span>
   <span class="font10">direct </span>
   <span class="font10">double; </span>
   <span class="font10">encephalitis </span>
   <span class="font10">even </span>
   <span class="font10">fluid </span>
   <span class="font10">further </span>
   <span class="font10">infected </span>
   <span class="font10">inhibitor </span>
   <span class="font10">insulin </span>
   <span class="font10">mucosal </span>
   <span class="font10">promising </span>
   <span class="font10">proposed </span>
   <span class="font10">region </span>
   <span class="font10">release </span>
   <span class="font10">since </span>
   <span class="font10">solid </span>
   <span class="font10">specific </span>
   <span class="font10">strategy </span>
   <span class="font10">studied </span>
   <span class="font10">substrate </span>
   <span class="font10">such </span>
   <span class="font10">therefore </span>
   <span class="font10">tight </span>
   <span class="font10">whereas </span>
   <span class="font10">ABC </span>
   <span class="font10">ABCC </span>
   <span class="font10">ATP-binding </span>
   <span class="font10">Administration </span>
   <span class="font10">CCR </span>
   <span class="font10">CNS. </span>
   <span class="font10">Deliv../.. </span>
   <span class="font10">Formulations </span>
   <span class="font10">Innovative </span>
   <span class="font10">ability </span>
   <span class="font10">agents </span>
   <span class="font10">allowed </span>
   <span class="font10">anti-HIV </span>
   <span class="font10">between </span>
   <span class="font10">binding </span>
   <span class="font10">blood </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">both </span>
   <span class="font10">characterized </span>
   <span class="font10">compounds </span>
   <span class="font10">concentration </span>
   <span class="font10">demonstrated </span>
   <span class="font10">drugs, </span>
   <span class="font10">elude </span>
   <span class="font10">evidenced </span>
   <span class="font10">immunodeficiency </span>
   <span class="font10">indeed </span>
   <span class="font10">indinavir </span>
   <span class="font10">induces </span>
   <span class="font10">interact </span>
   <span class="font10">levels </span>
   <span class="font10">model </span>
   <span class="font10">obtain </span>
   <span class="font10">pathways </span>
   <span class="font10">penetration </span>
   <span class="font10">permeate </span>
   <span class="font10">polymeric </span>
   <span class="font10">protease </span>
   <span class="font10">proteins </span>
   <span class="font10">rats </span>
   <span class="font10">receptors </span>
   <span class="font10">required </span>
   <span class="font10">reverse </span>
   <span class="font10">sanctuaries </span>
   <span class="font10">saquinavir, </span>
   <span class="font10">selective </span>
   <span class="font10">solid; </span>
   <span class="font10">strategies </span>
   <span class="font10">system. </span>
   <span class="font10">targeted </span>
   <span class="font10">those </span>
   <span class="font10">time </span>
   <span class="font10">trigeminal </span>
   <span class="font10">use </span>
   <span class="font10">used </span>
   <span class="font10">values </span>
   <span class="font10">via </span>
   <span class="font10">viral </span>
   <span class="font10">vivo </span>
   <span class="font10">when </span>
   <span class="font10">within </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">Can </span>
   <span class="font10">Drug </span>
   <span class="font10">Finally, </span>
   <span class="font10">MRP </span>
   <span class="font10">MRP, </span>
   <span class="font10">PVP </span>
   <span class="font10">Pharmacol../mol.. </span>
   <span class="font10">Recently, </span>
   <span class="font10">Taking </span>
   <span class="font10">Ther. </span>
   <span class="font10">Ther../jpet.. </span>
   <span class="font10">UDCA-AZT </span>
   <span class="font10">Venezuelan </span>
   <span class="font10">[,,,]. </span>
   <span class="font10">abacavir, </span>
   <span class="font10">act </span>
   <span class="font10">also </span>
   <span class="font10">amounts </span>
   <span class="font10">amprenavir, </span>
   <span class="font10">bioavailability </span>
   <span class="font10">bold </span>
   <span class="font10">cancer </span>
   <span class="font10">cause </span>
   <span class="font10">cerebrospinal </span>
   <span class="font10">clinical </span>
   <span class="font10">constitute </span>
   <span class="font10">courier; </span>
   <span class="font10">data </span>
   <span class="font10">designed </span>
   <span class="font10">developed </span>
   <span class="font10">disease </span>
   <span class="font10">dolutegravir </span>
   <span class="font10">drugs. </span>
   <span class="font10">easily </span>
   <span class="font10">efficient </span>
   <span class="font10">em; </span>
   <span class="font10">entry </span>
   <span class="font10">example, </span>
   <span class="font10">family </span>
   <span class="font10">gel </span>
   <span class="font10">hydrophilic </span>
   <span class="font10">immune </span>
   <span class="font10">junctions </span>
   <span class="font10">ligands </span>
   <span class="font10">lipid </span>
   <span class="font10">loaded </span>
   <span class="font10">membranes </span>
   <span class="font10">mice </span>
   <span class="font10">molecular </span>
   <span class="font10">molecules </span>
   <span class="font10">most </span>
   <span class="font10">necessary </span>
   <span class="font10">neurotropic </span>
   <span class="font10">nose </span>
   <span class="font10">optimize </span>
   <span class="font10">other </span>
   <span class="font10">peripheral </span>
   <span class="font10">probenecid </span>
   <span class="font10">protein </span>
   <span class="font10">pt;} </span>
   <span class="font10">rate </span>
   <span class="font10">ratio </span>
   <span class="font10">residence </span>
   <span class="font10">resistance-associated </span>
   <span class="font10">result </span>
   <span class="font10">ribavirin </span>
   <span class="font10">should </span>
   <span class="font10">show </span>
   <span class="font10">showed </span>
   <span class="font10">shows </span>
   <span class="font10">simplex </span>
   <span class="font10">studies </span>
   <span class="font10">them </span>
   <span class="font10">therapies </span>
   <span class="font10">tissue </span>
   <span class="font10">transcriptase </span>
   <span class="font10">ursodeoxycholic </span>
   <span class="font10">viruses </span>
   <span class="font10">well-known </span>
  </p>
 </body>
</html>
